Tokyo, Dec. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059749) titled 'Patient Journey in patients with fibrosing ILDs in Japan - A National Database Study' on Dec. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Nippon Boehringer Ingelheim Co., Ltd
Condition:
Condition - IPF, PPF, and non-progressive ILD
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To describe patient journey in patients with fibrosing Interstitial Lung Diseases (ILDs) in Japan.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients diagnosed w...